|
- New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug
- Eli Lillys weight loss drug retatrutide clears first late-stage study
The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill
- New weight loss drug dubbed triple G shows promise: What to know . . .
Retatrutide works by mimicking three hunger-regulating hormones A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising
- Lillys triple agonist, retatrutide, delivered weight loss of up to an . . .
About retatrutide Retatrutide is an investigational once-weekly triple hormone receptor agonist Retatrutide is a single molecule that activates the body's receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
- Lilly’s Retatrutide Scores Triple Trial Triumph With 26% . . . - BioSpace
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial Eli Lilly’s triple hormone receptor agonist cut body weight by 26 6% on a placebo-adjusted basis and reduced knee
- Retatrutide melts fat fast but at a cost warn experts - Diabetes
A new weight loss injection called retatrutide has shown remarkable results in helping users shed weight quickly However, recent research suggests that the drug, which is developed by the makers of Mounjaro, may come with concerning side effects, including bone fractures and kidney issues
- Next-gen Lilly drug leads to major weight loss, tolerability . . . - STAT
Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight
- Retatrutide: What is it and is it FDA approved? - Drugs. com
Current FDA approval status, regulatory history, and clinical trial results for retatrutide, an investigational treatment for obesity from the development pipeline at Eli Lilly and Company
|
|
|